New Strategy to Predict Early Sepsis

Status unconfirmed

Conditions studied: Sepsis

In brief

This is an observational prospective multicentre study on patients attending the emergency department and suspected to have sepsis. Blood markers characteristic of a Cellular Reprogramming (CR) signature and predicting severe sepsis and organ failure will be measured and validated.

Key facts

Study ID

NCT04118179

Run by

University of British Columbia

People needed

1000

Starts

2018-08-01

Expected to finish

2023-07-31

Last updated by the study team

2023-06-05

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female
• Presenting to the Emergency Department
• Attending physician suspects possible sepsis based on at least 2 sign of Systemic inflammatory response syndrome (SIRS) criteria and suspicion of infection

You may not qualify if…

• Patient is terminal (death anticipated in 12 hours)
• Informed consent unobtainable if the subject survives to hospital discharge.
• Subjects who are unable to provide blood as a standard of care.
• Blood sample could not be taken within 24 hours of a physician's first contact with the patient.

Where it is running

• University of Texas, M.D. Anderson Cancer Center — Houston, Texas, United States
• Westmead Hospital — Sydney, Australia
• Vancouver General Hospital — Vancouver, Canada
• Hospital Universitario Moncaleano Perdomo — Neiva, Colombia
• University Medical Center Groningen — Groningen, Netherlands

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.